Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

Myasthenia gravis (MG) is a well-recognised disorder of neuromuscular transmission that can be diagnosed by the presence of antibodies to the acetylcholine receptor (AChR). However, some patients (about 15%) with generalised MG do not have detectable AChR antibodies. There is some evidence, however,...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Vincent, A, Bowen, J, Newsom-Davis, J, McConville, J
Natura:	Journal article
Lingua:	English
Pubblicazione:	2003

Documenti analoghi

Seronegative myasthenia gravis.
di: Vincent, A, et al.
Pubblicazione: (2004)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
di: McConville, J, et al.
Pubblicazione: (2004)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
di: McConville, J, et al.
Pubblicazione: (2002)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
di: Newsom-Davis, J, et al.
Pubblicazione: (2001)

Myasthenia gravis seronegative for acetylcholine receptor antibodies.
di: Vincent, A, et al.
Pubblicazione: (2008)

Antibodies to AChRs in seronegative myasthenia gravis
di: Leite, M, et al.
Pubblicazione: (2006)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
di: Hoch, W, et al.
Pubblicazione: (2001)

Antibodies in myasthenia gravis and related disorders.
di: Vincent, A, et al.
Pubblicazione: (2003)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
di: Lee, J, et al.
Pubblicazione: (2006)

SERONEGATIVE MYASTHENIA GRAVIS-CLINICAL/SEROLOGICAL ASPECTS
di: Huda, S, et al.
Pubblicazione: (2014)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
di: Park, K, et al.
Pubblicazione: (2018)

Antibodies to clustered acetylcholine receptor and thymic changes in seronegative myasthenia gravis
di: Leite, M, et al.
Pubblicazione: (2007)

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
di: Leite, M, et al.
Pubblicazione: (2008)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
di: Kee Hong Park, et al.
Pubblicazione: (2018-01-01)

Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita.
di: Vincent, A, et al.
Pubblicazione: (1998)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
di: Yeh, J, et al.
Pubblicazione: (2004)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
di: Courtney Townsel, et al.
Pubblicazione: (2016-03-01)

Clinical and functional characteristics of seronegative and musk myasthenia gravis
di: Huda, S
Pubblicazione: (2017)

Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics
di: Paula Raquel do Vale Pascoal Rodrigues, et al.
Pubblicazione: (2024-01-01)

Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
di: Kee Hong Park, et al.
Pubblicazione: (2018-01-01)

Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients.
di: Jitpimolmard, S, et al.
Pubblicazione: (2006)

Clinical aspects of MuSK antibody positive seronegative MG.
di: Sanders, D, et al.
Pubblicazione: (2003)

Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
di: Damato, V, et al.
Pubblicazione: (2022)

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.
di: Nemoto, Y, et al.
Pubblicazione: (2005)

Improvement of fatigue in generalised myasthenia gravis with zilucoplan
di: Weiss, MD, et al.
Pubblicazione: (2024)

Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
di: Claudia Vinciguerra, et al.
Pubblicazione: (2023-09-01)

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
di: Palace, J, et al.
Pubblicazione: (1998)

Facial muscle atrophy in musk antibody positive myasthenia gravis
di: Farrugia, M, et al.
Pubblicazione: (2006)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
di: Jacob, S, et al.
Pubblicazione: (2008)

The impact of diagnosis delay on European patients with generalised myasthenia gravis
di: Elena Cortés‐Vicente, et al.
Pubblicazione: (2024-09-01)

Seronegative Myasthenia Gravis, as a Rare Autoimmune Condition in Turner Syndrome
di: Rimah Sharief, et al.
Pubblicazione: (2017-01-01)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma
di: Sun Yong Lee, et al.
Pubblicazione: (2020-05-01)

Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
di: Farrugia, M, et al.
Pubblicazione: (2006)

A systematic review of population based epidemiological studies in Myasthenia Gravis
di: McCarron Peter O, et al.
Pubblicazione: (2010-06-01)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
di: Farrugia, M, et al.
Pubblicazione: (2007)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
di: Farrugia, M, et al.
Pubblicazione: (2006)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
di: Deymeer, F, et al.
Pubblicazione: (2007)

Myasthenia gravis with MuSK antibodies
di: Farrugia, M, et al.
Pubblicazione: (2005)

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
di: Maddison, P, et al.
Pubblicazione: (2011)

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
di: Mygland, A, et al.
Pubblicazione: (2000)